Bigul

PARNAX LAB LTD. - 506128 - Board Meeting

In reference to the intimation made by the Company on 06.03.2020 regarding its Board meeting which is scheduled to be held on Monday 16th March, 2020, this is to bring to your kind notice that, period of re-appointment of Non-Executive Independent Director was Inadvertently mentioned as 01.04.2020 to 31.03.2025 instead of 31.03.2020 to 30.03.2025 while intimating to the stock exchange. In view of the above, we request you to kindly read it as 'To approve re-appointment of Mr. Tirunillai Anantharaman (DIN: 07147028) as a Non-Executive Independent Director of the Company for second term of 5 consecutive years for the period starting from 31.03 2020 to 30.03.2025, subject to approval of the members in the ensuing Annual General Meeting.' You are requested to kindly take the same on your record.
13-03-2020
Bigul

Parnax Lab Ltd - 506128 - Board Meeting Intimation for Appointment Of Independent Director Of The Company

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2020 ,inter alia, to consider and approve This is to inform you that, the meeting of the Board of Directors of the Company Parnax Lab Limited will be held on Monday, 16th March, 2020 at the registered office of the Company to transact the following business: 1. To approve re-appointment of Mr. Tirunillai Anantharaman (DIN: 07147028) as a Non-Executive Independent Director of the Company for second term of 5 consecutive years for the period starting from 1st April, 2020 to 31st March, 2025, subject to approval of the members in the ensuing Annual General Meeting. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. Kindly acknowledge the receipt of the same.
06-03-2020
Bigul

PARNAX LAB LTD. - 506128 - Financial Results For Quarter And Nine Months Ended 31.12.2019.

Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter and nine months ended 31st December 2019;
14-02-2020
Bigul

Parnax Lab Ltd - 506128 - Outcome Of Board Meeting

Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Friday,14th February, 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter ended 31st December 2019. 2. Considered and took note of Limited Review Report for the quarter ended 31st December, 2019. The Meeting was commenced at 4.00 p.m. and concluded at 7.15 p.m. Kindly take the same on your record.
14-02-2020
Bigul

Parnax Lab Ltd - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St December, 2019.

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Result along with Limited Review Report for the quarter ended 31st December, 2019 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.
03-02-2020
Bigul

Parnax Lab Ltd - 506128 - Shareholding for the Period Ended December 31, 2019

Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
15-01-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, In reference to the above captioned regulation we have received confirmation from our Registrar & Transfer Agents Link Intime India Pvt. Ltd., that since there were no dematerialization requests during the quarter ended 31st December 2019, therefore the Confirmation certificate as per Regulation 74 (5) is not applicable to the Company. This is for your information and records. Thanking you.
07-01-2020
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Namrata KambliDesignation :- Company Secretary and Compliance Officer
06-01-2020
Bigul

Parnax Lab Ltd - 506128 - Closure of Trading Window

Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No:LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons with effect from 01st January, 2020 for the purpose of consideration of Unaudited Financial result for the quarter ended 31st December, 2019. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter ended 31st December, 2019, become generally available to the Public. The above is for your information and record. Kindly take the same on your record and oblige.
31-12-2019
Bigul

PARNAX LAB LTD. - 506128 - Announcement Under Regulation 30 (LODR)-Board Meeting Update

This is to inform that in the meeting of the Board of Directors of the Company Parnax Lab Limited held on Tuesday, 26th November, 2019, Ms. Namrata Kambli has been appointed as Company Secretary and Compliance Officer w.e.f. 26th November, 2019.
26-11-2019
Next Page
Close

Let's Open Free Demat Account